Publizoom

Mylan EPD (Entiteit van Viatris)

Company number 0885.805.780

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
5
Amount won alone
€8,945,901 excl. VAT
Shared contracts
2 (multi-supplier framework agreements)
Period
29 April 2024 – 18 August 2025

Its main clients

Where and what

Supplies · 5

Antwerp · 3 East Flanders · 1 West Flanders · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
12 April 2029
re-tender around October 2028
Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen
EMMAUS VZW framework agreement
EUROGENERICS SA
Novartis Pharma
PFIZER SA
Accord Healthcare BV
SANDOZ NV
AREGA PHARMA BVBA
Mylan EPD (Entiteit van Viatris)
4 bids received
€874,780
19 April 2029
re-tender around October 2028
Heparines met laag moleculair gewicht bij preventie en dialyse
EMMAUS VZW framework agreement
Mylan EPD (Entiteit van Viatris)
1 bid received
€525,146
5 August 2029
re-tender around February 2029
Raamovereenkomst voor het leveren van sugammadex IV
AZ Oudenaarde framework agreement
Mylan EPD (Entiteit van Viatris)
2 bids received
€7,720,755

Contracts won

DateContractBuyerAmount
18/08/2025 Raamovereenkomst voor het leveren van sugammadex IV AZ Oudenaarde €7,720,755
04/06/2025 Heparines met laag moleculair gewicht bij preventie en dialyse EMMAUS VZW €525,146
04/06/2025 Diverse geneesmiddelen oncologie PO voor Helixziekenhuizen EMMAUS VZW €874,780
shared by 7
31/01/2025 TAX_Geneesmiddel_sugammadex Sint-Dimpna Ziekenhuis Geel €700,000
29/04/2024 Raamovereenkomst voor leveren van Cytostatica geneesmiddelen AZ Sint-Jan Brugge AV €3,379,003
shared by 10

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.